Amgen Inc.

Status: Publicly traded

Direct answer

Amgen Inc. is publicly traded on NASDAQ under the ticker AMGN.

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience....

Can you invest in Amgen Inc.?

Yes. Amgen Inc. is publicly traded on NASDAQ under the ticker AMGN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Amgen Inc.

Detailed equity research is provided by MarketSnap.